Your session is about to expire
← Back to Search
Exparel 133 MG Per 10 ML Injection for Shoulder Pain
Phase 4
Waitlist Available
Led By David Kim, MD
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
ASA I-III
Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24, 48, 72, 96 (if needed) hours postoperatively
Awards & highlights
Study Summary
This trial is testing two different pain management techniques for shoulder surgery patients - one with just bupivacaine and one with bupivacaine and dexamethasone. Researchers will be looking at pain levels and block duration afterwards.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24, 48, 72, 96 (if needed) hours postoperatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24, 48, 72, 96 (if needed) hours postoperatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Numerical Rating Scale (NRS) Pain at Rest Over 72 Hours
Secondary outcome measures
Brief Pain Inventory Short-form
Duration of Analgesic Block
Motor Block Resolution
+7 moreSide effects data
From 2021 Phase 4 trial • 112 Patients • NCT0404744614%
Postoperative neurologic symptoms at 7 days after surgery
100%
80%
60%
40%
20%
0%
Study treatment Arm
Liposomal Bupivacaine & Standard Bupivacaine
Standard Bupivacaine & Dexamethasone
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Liposomal bupivacaine & standard bupivacaineExperimental Treatment1 Intervention
Group II: Standard bupivacaine & dexamethasoneActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved
Find a Location
Who is running the clinical trial?
Hospital for Special Surgery, New YorkLead Sponsor
242 Previous Clinical Trials
61,790 Total Patients Enrolled
2 Trials studying Shoulder Pain
210 Patients Enrolled for Shoulder Pain
David Kim, MDPrincipal InvestigatorHospital for Special Surgery, New York
1 Previous Clinical Trials
94 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger